Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join Olink users, consortia, events and webinars to share insights and accelerate biomarker discovery.
Comprehensive statistical analysis & data visualization tools
Over 4,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
The Journal of Infectious Diseases, 2024Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19
Strunz B., Maucourant C., Mehta A. et al.
Olink Explore 3072/384
Science Translational Medicine, 2024APOE from patient-derived astrocytic extracellular vesicles alleviates neuromyelitis optica spectrum disorder in a mouse model
Jiang, S., Li et al.
Olink Target 96 Mouse
The Journal of Clinical Endocrinology & Metabolism, 2024Magnesium Supplementation Modulates T-cell Function in People with Type 2 Diabetes and Low Serum Magnesium Levels
Drenthen L., Ajie M., de Baaij J. et al.
Olink Target 96
Cell Genomics, 2024Genetic associations with ratios between protein levels detect new pQTLs and reveal protein-protein interactions
Suhre K.
ESC Heart Failure, 2024Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement
Beuthner B., Elkenani M., Evert K. et al.
Translational Oncology, 2024CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC
Salvermoser L., Goldberg S., Alunni-Fabbroni M. et al.
Journal of Clinical Periodontology, 2024LIGHT protein: A novel gingival crevicular fluid biomarker associated with increased probing depth after periodontal surgery
Esberg A., Kindstedt E., Isehed C. et al.
Journal of Clinical Immunology, 2024Thymic Atrophy and Immune Dysregulation in Infants with Complex Congenital Heart Disease
Bremer S., Boxnick A., Glau L. et al.
International Journal of Cancer, 2024Exploring causal correlations between circulating levels of cytokines and colorectal cancer risk: A Mendelian randomization analysis
Meng C., Sun L., Shi J. et al.
World Journal of Urology, 2024Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy
Guldvik I., Ramberg H., Kristensen G. et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2024Differences in Cardiometabolic Proteins in Pregnancy Prioritize Relevant Targets of Preeclampsia
Lindley K., Perry A., Jacobs M. et al.
Frontiers in Immunology, 2024Vitreous Olink proteomics reveals inflammatory biomarkers for diagnosis and prognosis of traumatic proliferative vitreoretinopathy
Guo H., Wang T., Yu J. et al.
Frontiers in Immunology, 2024Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19
Baranova A., Luo J., Fu L. et al.
Nature Communications, 2024Converging and evolving immuno-genomic routes toward immune escape in breast cancer
Blanco-Heredia J., Souza C., Trincado J. et al.
Molecular Cancer, 2024Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide
Toulmonde M., Guegan J., Spalato-Ceruso M. et al.
Acta Biomaterialia, 2024Increased matrix stiffness enhances pro-tumorigenic traits in a physiologically relevant breast tissue- monocyte 3D model
Abrahamsson A., Boroojeni F., Naeimipour S. et al.
Annals of the Rheumatic Diseases, 2024Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker
Ea H., Kischkel B., Chirayath T. et al.
Dermatology and Therapy, 2024Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Ludbrook V., Budd D., Thorn K. et al.
Journal of Autoimmunity, 2024The enigma of sclera-specific autoimmunity in scleritis
Vergouwen D., van Beek A., de Hoog J. et al.
Computers in Biology and Medicine, 2024Exploring metformin monotherapy response in Type-2 diabetes: Computational insights through clinical, genomic, and proteomic markers using machine learning algorithms
Villikudathil A., Mc Guigan D., English A.
4342 publications
Items per page
2641-2660 of 4342 publications